Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead  — Boosted by Taxpayers

Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers

It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths...
read more